Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 May 1;114(6):771-772.
doi: 10.1093/cvr/cvy062.

A new strategy to decrease cardiac injury in aged heart following ischaemia-reperfusion: enhancement of the interaction between AMPK and SIRT1

Affiliations
Editorial

A new strategy to decrease cardiac injury in aged heart following ischaemia-reperfusion: enhancement of the interaction between AMPK and SIRT1

Qun Chen et al. Cardiovasc Res. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Activation of SIRT1 and AMPK decreases cardiac injury in aged hearts following IR. Aging and IR decreases SIRT1 activity that leads to decreased AMPK activity through acetylation and subsequent inhibition of LKB1. Deactivation of AMPK also affects SIRT1 activity due to altered NAD+ concentration. Sestrin 2 may also interact and affect AMPK activation. Deactivation of SIRT1 and AMPK leads to decreased glucose oxidation and increased fatty acid oxidation (FAO) that contribute to increased injury in aged hearts following IR. Aging also impairs mtDNA that increases ROS generation by inhibiting Complex III at mitochondrial ETC. IR leads to decreased PDH activity that also leads to altered metabolism in hearts with decreased glucose oxidation and increased FAO. Activation of SIRT1 and AMPK is a promising approach to decrease cardiac injury in aged hearts following IR.

Comment on

Similar articles

Cited by

References

    1. Lesnefsky EJ, Chen Q, Hoppel CL.. Mitochondrial metabolism in aging heart. Circ Res 2016;118:1593–1611. - PMC - PubMed
    1. Lesnefsky EJ, Lundergan CF, Hodgson JM, Nair R, Reiner JS, Greenhouse SW, Califf RM, Ross AM.. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience. J Am Coll Cardiol 1996;28:331–337. - PubMed
    1. Kolwicz SC Jr, Tian R.. Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization? Trends Cardiovasc Med 2009;19:201–207. - PMC - PubMed
    1. Wang L, Quan N, Sun W, Chen X, Cates C, Rousselle T, Zhou X, Zhao X, Li J.. Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury. Cardiovasc Res 2018;114:805–821. - PMC - PubMed
    1. Stein SC, Woods A, Jones NA, Davison MD, Carling D.. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 2000;345(Pt 3):437–443. - PMC - PubMed

Publication types